showed that pancreatic cancer cells express Galectin-9, which can inhibit CD8+ T cells by binding to T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) (42). The gene discussed is HAVCR2; the disease is familial pancreatic carcinoma.